GILEAD SCIENCES, INC. — Director's Dealing 2015

Feb 3, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2015-02-01

Reporting Person: MILLIGAN JOHN F (President and COO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-02-01	Non-Qualified Stock Option (right to buy)	$104.83	A	70290	Acquired	2025-02-01	Common Stock (70290)	Direct

Footnotes

F1: The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.